Two suspects were arrested on a series of drug charges by Baldwin police on Oct. 21, according to authorities.
The Baldwin Police Department took nearly two months to provide the incident report, which was requested on Friday, Oct. 25.
According to the report, a Baldwin police officer responded to the Carwood Building (Chatham Street at Williams Street) in reference to a suspicious vehicle.
On scene, the officer approached the driver’s side and allegedly detected an odor of marijuana. The driver, Zackary Sean Tamisiea, 30, and passenger Katelyn Ruth Ensley, 23, both of Blairsville, were the only occupants of the vehicle.
Tamisiea appeared nervous and allegedly “under the influence of drugs,” according to the report, before the two admitted to smoking marijuana. One of the two passenger’s held a lit joint in hand, the report states.
Officers ordered the two suspects to exit the vehicle, and while Ensley complied, Tamisiea was “hesitant,” according to police, and asked if the investigation was necessary. Then he allegedly placed a hand behind his back, where police say a knife was later found.
Tamisiea exited the vehicle and was detained immediately, according to authorities, as officers conducted a search on the car.
Inside, officers allegedly located $500 cash, a bank card belonging to another person, a small bag of methamphetamine and a glass smoking device.
Inside a red tube-like container, the report states police also located three more bags of methamphetamine, one bag of a gray powdery substance suspected to be fentanyl, one bag of blue pills believed to be oxycodone, and in another yellow container, three bags of marijuana, smoking straws and THC gummies.
Tamisiea was arrested and charged with four counts of schedule I or II controlled substance, two counts of a schedule I controlled substance, and two counts of a schedule II controlled substance.
Ensley also was arrested and charged with four counts of schedule I or II controlled substance, two counts of a schedule I controlled substance, and two counts of a schedule II controlled substance.
